Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Type 2 Diabetes Therapeutics Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 DPP-4 inhibitors
  • 1.3.3 Biguanides
  • 1.3.4 Insulins
  • 1.3.5 GLP-1 receptor agonists
  • 1.3.6 Thiazolidenediones
  • 1.3.7 Sulfonulureas
  • 1.3.8 SGLT-2 inhibitors
  • 1.3.9 A-Glucosidase inhibitors
  • 1.3.10 Others
• 1.4 Market Segment by Application
  • 1.4.1 Global Type 2 Diabetes Therapeutics Market Share by Application (2019-2025)
  • 1.4.2 Hospital Pharmacy
  • 1.4.3 Retail Pharmacies
  • 1.4.4 Online Pharmacy
  • 1.4.5 Others
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Type 2 Diabetes Therapeutics Market Size
  • 2.1.1 Global Type 2 Diabetes Therapeutics Revenue 2014-2025
  • 2.1.2 Global Type 2 Diabetes Therapeutics Sales 2014-2025
• 2.2 Type 2 Diabetes Therapeutics Growth Rate by Regions
  • 2.2.1 Global Type 2 Diabetes Therapeutics Sales by Regions 2014-2019
  • 2.2.2 Global Type 2 Diabetes Therapeutics Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Type 2 Diabetes Therapeutics Sales by Manufacturers
  • 3.1.1 Type 2 Diabetes Therapeutics Sales by Manufacturers 2014-2019
  • 3.1.2 Type 2 Diabetes Therapeutics Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Type 2 Diabetes Therapeutics Revenue by Manufacturers (2014-2019)
  • 3.2.2 Type 2 Diabetes Therapeutics Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Type 2 Diabetes Therapeutics Market Concentration Ratio (CR5 and HHI)
• 3.3 Type 2 Diabetes Therapeutics Price by Manufacturers
• 3.4 Key Manufacturers Type 2 Diabetes Therapeutics Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Type 2 Diabetes Therapeutics Market
• 3.6 Key Manufacturers Type 2 Diabetes Therapeutics Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 DPP-4 inhibitors Sales and Revenue (2014-2019)
  • 4.1.2 Biguanides Sales and Revenue (2014-2019)
  • 4.1.3 Insulins Sales and Revenue (2014-2019)
  • 4.1.4 GLP-1 receptor agonists Sales and Revenue (2014-2019)
  • 4.1.5 Thiazolidenediones Sales and Revenue (2014-2019)
  • 4.1.6 Sulfonulureas Sales and Revenue (2014-2019)
  • 4.1.7 SGLT-2 inhibitors Sales and Revenue (2014-2019)
  • 4.1.8 A-Glucosidase inhibitors Sales and Revenue (2014-2019)
  • 4.1.9 Others Sales and Revenue (2014-2019)
• 4.2 Global Type 2 Diabetes Therapeutics Sales Market Share by Type
• 4.3 Global Type 2 Diabetes Therapeutics Revenue Market Share by Type
• 4.4 Type 2 Diabetes Therapeutics Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Type 2 Diabetes Therapeutics Sales by Application

6 United States

• 6.1 United States Type 2 Diabetes Therapeutics Breakdown Data by Company
• 6.2 United States Type 2 Diabetes Therapeutics Breakdown Data by Type
• 6.3 United States Type 2 Diabetes Therapeutics Breakdown Data by Application

7 European Union

• 7.1 European Union Type 2 Diabetes Therapeutics Breakdown Data by Company
• 7.2 European Union Type 2 Diabetes Therapeutics Breakdown Data by Type
• 7.3 European Union Type 2 Diabetes Therapeutics Breakdown Data by Application

8 China

• 8.1 China Type 2 Diabetes Therapeutics Breakdown Data by Company
• 8.2 China Type 2 Diabetes Therapeutics Breakdown Data by Type
• 8.3 China Type 2 Diabetes Therapeutics Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Type 2 Diabetes Therapeutics Breakdown Data by Company
• 9.2 Rest of World Type 2 Diabetes Therapeutics Breakdown Data by Type
• 9.3 Rest of World Type 2 Diabetes Therapeutics Breakdown Data by Application
• 9.4 Rest of World Type 2 Diabetes Therapeutics Breakdown Data by Countries
  • 9.4.1 Rest of World Type 2 Diabetes Therapeutics Sales by Countries
  • 9.4.2 Rest of World Type 2 Diabetes Therapeutics Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 AstraZeneca
  • 10.1.1 AstraZeneca Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Type 2 Diabetes Therapeutics
  • 10.1.4 Type 2 Diabetes Therapeutics Product Introduction
  • 10.1.5 AstraZeneca Recent Development
• 10.2 Novartis
  • 10.2.1 Novartis Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Type 2 Diabetes Therapeutics
  • 10.2.4 Type 2 Diabetes Therapeutics Product Introduction
  • 10.2.5 Novartis Recent Development
• 10.3 Novo Nordisk
  • 10.3.1 Novo Nordisk Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Type 2 Diabetes Therapeutics
  • 10.3.4 Type 2 Diabetes Therapeutics Product Introduction
  • 10.3.5 Novo Nordisk Recent Development
• 10.4 Boehringer Ingelheim
  • 10.4.1 Boehringer Ingelheim Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Type 2 Diabetes Therapeutics
  • 10.4.4 Type 2 Diabetes Therapeutics Product Introduction
  • 10.4.5 Boehringer Ingelheim Recent Development
• 10.5 Bristol-Myers Squibb
  • 10.5.1 Bristol-Myers Squibb Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Type 2 Diabetes Therapeutics
  • 10.5.4 Type 2 Diabetes Therapeutics Product Introduction
  • 10.5.5 Bristol-Myers Squibb Recent Development
• 10.6 Eli Lilly
  • 10.6.1 Eli Lilly Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Type 2 Diabetes Therapeutics
  • 10.6.4 Type 2 Diabetes Therapeutics Product Introduction
  • 10.6.5 Eli Lilly Recent Development
• 10.7 Merck
  • 10.7.1 Merck Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Type 2 Diabetes Therapeutics
  • 10.7.4 Type 2 Diabetes Therapeutics Product Introduction
  • 10.7.5 Merck Recent Development
• 10.8 Sanofi
  • 10.8.1 Sanofi Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Type 2 Diabetes Therapeutics
  • 10.8.4 Type 2 Diabetes Therapeutics Product Introduction
  • 10.8.5 Sanofi Recent Development
• 10.9 Astellas Pharma
  • 10.9.1 Astellas Pharma Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of Type 2 Diabetes Therapeutics
  • 10.9.4 Type 2 Diabetes Therapeutics Product Introduction
  • 10.9.5 Astellas Pharma Recent Development
• 10.10 Daiichi Sankyo
  • 10.10.1 Daiichi Sankyo Company Details
  • 10.10.2 Company Description and Business Overview
  • 10.10.3 Sales, Revenue and Market Share of Type 2 Diabetes Therapeutics
  • 10.10.4 Type 2 Diabetes Therapeutics Product Introduction
  • 10.10.5 Daiichi Sankyo Recent Development
• 10.11 Biocon

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Type 2 Diabetes Therapeutics Sales Channels
  • 11.2.2 Type 2 Diabetes Therapeutics Distributors
• 11.3 Type 2 Diabetes Therapeutics Customers

12 Market Forecast

• 12.1 Global Type 2 Diabetes Therapeutics Sales and Revenue Forecast 2019-2025
• 12.2 Global Type 2 Diabetes Therapeutics Sales Forecast by Type
• 12.3 Global Type 2 Diabetes Therapeutics Sales Forecast by Application
• 12.4 Type 2 Diabetes Therapeutics Forecast by Regions
  • 12.4.1 Global Type 2 Diabetes Therapeutics Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Type 2 Diabetes Therapeutics Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

In 2019, the market size of Type 2 Diabetes Therapeutics is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Type 2 Diabetes Therapeutics.

This report studies the global market size of Type 2 Diabetes Therapeutics, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Type 2 Diabetes Therapeutics sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
AstraZeneca
Novartis
Novo Nordisk
Boehringer Ingelheim
Bristol-Myers Squibb
Eli Lilly
Merck
Sanofi
Astellas Pharma
Daiichi Sankyo
Biocon

Market Segment by Product Type
DPP-4 inhibitors
Biguanides
Insulins
GLP-1 receptor agonists
Thiazolidenediones
Sulfonulureas
SGLT-2 inhibitors
A-Glucosidase inhibitors
Others

Market Segment by Application
Hospital Pharmacy
Retail Pharmacies
Online Pharmacy
Others

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Type 2 Diabetes Therapeutics status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Type 2 Diabetes Therapeutics manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Type 2 Diabetes Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025